Pet Diabetes Care Devices Market, By Animal Type (Dogs and Cats), By Solutions (Treatment (Insulin Therapy, Insulin Delivery Devices, Other Treatments), and Glucose Monitoring Devices), By End User (Veterinary Clinics, Home Care Settings, and Veterinary H

Pet Diabetes Care Devices Market, By Animal Type (Dogs and Cats), By Solutions (Treatment (Insulin Therapy, Insulin Delivery Devices, Other Treatments), and Glucose Monitoring Devices), By End User (Veterinary Clinics, Home Care Settings, and Veterinary Hospitals), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

The global pet diabetes care devices market has been witnessing significant growth in the recent times. Rising pet obesity levels and increasing pet humanization have resulted in greater awareness about pet health, preventive care, and treatment of pet diseases. Pet owners are making active efforts towards monitoring blood glucose levels and managing diabetes in pets through insulin administration and therapeutic diet. Various technologies have been developed for diabetes management in pets which enables the non-invasive monitoring and administration of insulin doses. Advancements in continuous glucose monitoring (CGM) systems, insulin pumps, and lancing devices have simplified diabetes care for pets. Growing pet insurance coverage and rising pet care expenditure also supports the demand for specialized pet diabetes care devices. However, high cost of devices and therapy remains a key challenge for market growth.

(Market Dynamics):

Key factors, such as rising pet obesity, growing pet ownership in developing nations, increasing awareness about pet health and disease management, new product launches, and technological advancements, are fueling the growth of global pet diabetes care devices market. However, high cost associated with glucose monitoring devices, therapy and veterinary care is a major factor hampering the widespread adoption of these technologies. Market players are focusing on developing affordable solutions through innovations to expand their customer base in developing regions. Rising venture capital funding in pet care startups indicate strong opportunities for development of novel solutions as well as penetration in untapped markets.

(Key Features of the Study):

• This report provides in-depth analysis of the global pet diabetes care devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pet diabetes care devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., i-SENS, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pet diabetes care devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pet diabetes care devices market.

Detailed Segmentation-

• By Animal Type
• Dogs
• Cats
• By Solutions
• Treatment
• Insulin Therapy
• Insulin Delivery Devices
• Other Treatments
• Glucose Monitoring Devices
• By End User
• Veterinary Clinics
• Home Care Settings
• Veterinary Hospitals
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Key Players Insights
• Abbot Laboratories, Inc
• Virbac
• Medtronic plc
• Johnson & Johnson Services, Inc
• Roche Diagnostics
• Bio-Rad Laboratories, Inc
• Novo Nordisk A/S
• Zoetis Inc
• Terumo Corporation
• Boehringer Ingelheim International GmbH
• IDEXX Laboratories
• Johnson & Johnson Services, Inc
• Terumo Corporation
• Eli Lilly and Company
• Vetoquinol S.A.
• i-SENS, Inc.